KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Neogenomics (NEO) over the last 13 years, with Q4 2025 value amounting to -$2.5 million.

  • Neogenomics' Tax Provisions fell 21405.47% to -$2.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.2 million, marking a year-over-year decrease of 1508.47%. This contributed to the annual value of -$2.2 million for FY2025, which is 1508.47% down from last year.
  • As of Q4 2025, Neogenomics' Tax Provisions stood at -$2.5 million, which was down 21405.47% from $740000.0 recorded in Q3 2025.
  • In the past 5 years, Neogenomics' Tax Provisions registered a high of $976000.0 during Q1 2021, and its lowest value of -$5.7 million during Q2 2022.
  • Over the past 5 years, Neogenomics' median Tax Provisions value was -$2.4 million (recorded in 2021), while the average stood at -$1.8 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first plummeted by 74238.81% in 2021, then skyrocketed by 59333.33% in 2025.
  • Neogenomics' Tax Provisions (Quarter) stood at -$2.4 million in 2021, then decreased by 16.03% to -$2.8 million in 2022, then soared by 66.16% to -$960000.0 in 2023, then grew by 16.25% to -$804000.0 in 2024, then tumbled by 214.05% to -$2.5 million in 2025.
  • Its Tax Provisions stands at -$2.5 million for Q4 2025, versus $740000.0 for Q3 2025 and -$724000.0 for Q2 2025.